Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, December 28 2024)

Image
By G.M.

 


    Ann Intern Med


  1. Annals Video Summary - Anticoagulation Among Patients Hospitalized for COVID-19.
    Ann Intern Med. 2024 Dec 24:e2403257VS. doi: 10.7326/ANNALS-24-03257.
    PubMed        

  2. VALE CL, Godolphin PJ, Fisher DJ, Higgins JPT, et al
    Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.
    Ann Intern Med. 2024 Dec 24. doi: 10.7326/ANNALS-24-00800.
    PubMed         Abstract available

  3. SHAPPELL CN, Anesi GL
    Anticoagulation for COVID-19: Seeking Clarity and Finding Yet More Gray.
    Ann Intern Med. 2024 Dec 24. doi: 10.7326/ANNALS-24-03244.
    PubMed        


    Clin Chem

  4. FALAK S, O'Sullivan DM, Cleveland MH, Cowen S, et al
    The Application of Digital PCR as a Reference Measurement Procedure to Support the Accuracy of Quality Assurance for Infectious Disease Molecular Diagnostic Testing.
    Clin Chem. 2024 Dec 26:hvae187. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  5. KITI MC, Sacoor C, Aguolu OG, Zelaya A, et al
    Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022.
    Emerg Infect Dis. 2025;31:94-103.
    PubMed         Abstract available

  6. ENGELI V, Roussos S, Demiris N, Hatzakis A, et al
    Social Contact Patterns and Age Mixing before and during COVID-19 Pandemic, Greece, January 2020-October 2021.
    Emerg Infect Dis. 2025;31:75-85.
    PubMed         Abstract available

  7. MA J, Yang Y, Huang Y
    Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990-2022.
    Emerg Infect Dis. 2025;31:14-21.
    PubMed         Abstract available


    Int J Infect Dis

  8. CHEN X, Chen H, Tao F, Chen Y, et al
    Global analysis of influenza epidemic characteristics in the first two seasons after lifting the non-pharmaceutical interventions for COVID-19.
    Int J Infect Dis. 2024 Dec 20:107372. doi: 10.1016/j.ijid.2024.107372.
    PubMed         Abstract available


    J Med Virol

  9. WANG C, Yang Y, Wu K, Wang C, et al
    An Outbreak of Human Adenovirus Infection Among Children Post COVID-19 Pandemic in Southern China.
    J Med Virol. 2024;96:e70139.
    PubMed         Abstract available

  10. LI K, Wu Y, Zhang H, Chen S, et al
    A Novel Circular Delta-XBB15 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS-CoV-2 Variants in Mice.
    J Med Virol. 2024;96:e70134.
    PubMed         Abstract available

  11. GOSERT R, Koller R, Meyer J, Drager S, et al
    Multicenter Evaluation of the QIAstat-Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens.
    J Med Virol. 2024;96:e70129.
    PubMed         Abstract available


    Radiology

  12. FINNIGAN LEM, Cassar MP, Jafarpour M, Sultana A, et al
    (1)H and (31)P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.
    Radiology. 2024;313:e233173.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »